Related Experiment Video
Updated: Dec 28, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Cortactin Expression in Hematopoietic Cells: Implications for Hematological Malignancies.
Ramón Castellanos-Martínez1, Karina E Jiménez-Camacho1, Michael Schnoor1
1Department of Molecular Biomedicine, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Mexico City, Mexico.
Cortactin, a protein regulating cell adhesion and migration, is now functionally expressed in hematopoietic cells. Its overexpression in leukemia correlates with poor prognosis and treatment failure.
Area of Science:
- Hematology
- Oncology
- Cell Biology
Background:
- Cortactin is an actin-binding protein crucial for cell adhesion and migration.
- Overexpression of cortactin in solid tumors is linked to metastasis and poor outcomes.
- Previously thought absent in hematopoietic cells, recent evidence shows functional cortactin expression.
Purpose of the Study:
- To review cortactin expression in hematopoietic cells.
- To discuss the functional implications of cortactin in hematological malignancies.
Main Methods:
- Literature review of recent reports on cortactin expression and function.
- Analysis of cortactin's role in various hematological malignancies.
Main Results:
- Cortactin is functionally expressed in macrophages, dendritic cells, and lymphocytes.
- Cortactin is overexpressed in leukemic cell lines and patient samples.
- High cortactin levels are associated with poor prognosis in B-cell chronic lymphocytic leukemia and B-cell acute lymphoblastic leukemia.
- Cortactin is a potential diagnostic marker for non-Hodgkin B-cell lymphomas.
Conclusions:
- Cortactin plays a significant role in hematological malignancies.
- Cortactin expression levels impact patient prognosis and treatment outcomes.
- Further research into cortactin's function in hematopoiesis and leukemia is warranted.
More Related Videos
10:21Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells
Published on: January 5, 2018
08:14Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Hematopoiesis
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Differentiation of Common Myeloid Progenitor Cells
Multipotency of Hematopoietic Stem Cells